DKBmed, Transroad, and Guangci Address Chronic Hepatitis B (HBV) in the Country with the Largest Population of People Living with HBV, China
NEW YORK (1/29/2023) – DKBmed, LLC, Transroad Language Service Studio (Transroad), and Zhejiang Guangci Medical & Nursing Co., Ltd. (Guangci), have partnered to develop an interactive webinar for health care providers in China addressing critical gaps in provider knowledge around screening, diagnosing, and managing hepatitis B virus (HBV) infection, The HBV Learning Lab. With the help of our international partners, this initiative screening and treatment protocols for HBV and will provide participants with expert-based insight on how to recognize barriers to HBV management, particularly in traditionally marginalized populations. The webinar, which will be offered six times over the course of three months, will consist of a lecture by expert faculty and a question-and-answer session.
This program will launch on Saturday, January 27 at 10pm ET. Registration will be available at www.gc-mn.com
According to the World Health Organization (WHO), nearly 300 million people globally live with chronic HBV infection, with 1.5 million new infections occurring each year. In China, 87 million people live with chronic HBV, representing one-third of the world’s HBV carriers. China currently faces challenges in meeting HBV elimination targets set by the WHO, despite the country’s progress over recent decades with the birth-dose vaccine and childhood vaccinations.
While China is ethnically and culturally diverse, the mainstream Chinese culture does not largely embrace diversity. As a result, stigma and discrimination against historically marginalized groups at high risk of HBV infection, such as men who have sex with men and sex workers, create barriers in the optimal provision of HBV screening, diagnosis, and care. Unfortunately, only about 10% of those with HBV who require treatment are receiving appropriate treatment.
“Because of the strong stigma in China around STIs like hepatitis B, many people may be ashamed to get tested and health care providers may not test their patients because they don’t want to offend them,” notes Ke-Qin Hu, MD, FAASLD the Director of Hepatology Services and Professor of Medicine at the University of California, Irvine School of Medicine and HBV Learning Lab faculty. “As clinicians we need to educate ourselves and our patients to overcome the stigma around HBV, so that we can treat those that need it, and reduce the morbidity and mortality that HBV can cause.”
To close gaps in HBV screening and care in China, DKBmed’s webcast program will allow participants the opportunity to collaborate with Chinese and international HBV experts to develop effective screening and treatment protocols for their patients. The program’s webcasts and question-and-answer sessions will be made available as an enduring program for clinicians unable to attend the live sessions.
In The HBV Learning Lab, participants will expect to improve their ability to:
- Recognize patients who may be at risk for HBV infection
- Implement HBV screening protocols
- Understand and implement appropriate treatment options for HBV
- Manage coinfections in patients with chronic HBV
- Recognize barriers to HBV management
Disclosure of Support
This program is supported by an independent educational grant provided by Gilead Sciences, Inc.
About Transroad
Transroad has rich medical and technical resources in China and around the world and has IO years' experience in the development and operation of medical education and training programs, and Transroad has provided training services for educational and rraining cooperation projects of international and domestic famous medical institutions such as Johns Hopkins Nursing. Mayo Clinic, MD Anderson Cancer Center, School of Nursing of Nanjing Medical University, Qilu Hospital, etc., and accumulated rich experience in related projects.
About Guangci
Guangci Medical was established in 2016, with the mission of supporting the national "National Health" strategy, building an international specialist nurse certification education system with a trinity of "training, examination and certification", and is committed to providing Chinese nurses with world-leading specialist nursing training and personality Continuing nursing education improves nurses’ innovation, leadership, and competitiveness, allows more patients to enjoy global high-quality nursing services, helps improve patient recovery effects, and thereby enhances the professional value of specialist nurses.
About DKBmed
DKBmed is an integrated continuing medical education company operated by a team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.Working with accredited providers, DKBmed develops innovative educational programs and quality improvement (QI) initiatives and specializes in bringing new learning methodologies to the CME landscape. DKBmed has become a leader in QI in the independent medical education space with QI projects in pain management, HIV, depression, and diabetic retinopathy. DKBmed was also an early adopter of case scenarios with recorded and live actors, TED/DKBmed Talks, 3D animation, webcasts, podcasts, e-mail, and mobile phone applications for clinicians and patients. These forward-thinking approaches enable health care professionals to learn using state-of-the-art techniques and access educational programs in a manner that is most convenient and appropriate for them.
DKBmed’s programs are accessible through the company’s website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.